SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 131 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $316,000 | -59.0% | 32,200 | -54.1% | 0.01% | -50.0% |
| Q1 2016 | $771,000 | +24.0% | 70,121 | +3.8% | 0.02% | +17.6% |
| Q4 2015 | $622,000 | +4.9% | 67,578 | -20.9% | 0.02% | -15.0% |
| Q3 2015 | $593,000 | +113.3% | 85,471 | +201.9% | 0.02% | +150.0% |
| Q2 2015 | $278,000 | -10.6% | 28,310 | -19.2% | 0.01% | -20.0% |
| Q1 2015 | $311,000 | -13.9% | 35,055 | -14.9% | 0.01% | -23.1% |
| Q4 2014 | $361,000 | +24.5% | 41,174 | -2.1% | 0.01% | +30.0% |
| Q3 2014 | $290,000 | +61.1% | 42,053 | +17.8% | 0.01% | +11.1% |
| Q4 2013 | $180,000 | +26.8% | 35,700 | +27.0% | 0.01% | +50.0% |
| Q3 2013 | $142,000 | +10.9% | 28,100 | +8.9% | 0.01% | -40.0% |
| Q2 2013 | $128,000 | – | 25,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
| GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
| Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
| FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
| MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
| Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
| Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
| GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
| Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
| Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |